Research Tree Research Tree Logo

  • Try our Investor Tool
  • Login
  • Sign Up

Research Tree Logo

  • Login
  • Sign Up
  • Features
  • Pricing
  • Reg.News
  • Contact
  • Try our Investor Tool
  • Login
  • Sign Up
  • Providers
  • Companies
⨯
LIVE

Event in Progress:

Join Here ×
  • Providers
  • Companies
⨯
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest
  • Contact
Companies >
UK >
Medical Equipment & Services >
RUA Life Sciences Plc >
Research >
The pandemic clouds disperse

working
  • 27 May 2022

The pandemic clouds disperse


RUA Life Sciences Plc (RUA:LON) | 41.0 0 0.0% | Mkt Cap: 9.10m


  • Equity Development
    • Andy Smith

    • 5 pages


 

RUA Life Sciences’ trading update illustrated both a recovery from the challenges of the pandemic faced by medical device companies which translated into increased revenues at RUA Medical Devices and increased investment in its vascular and heart valve products. RUA’s cash balance has decreased from £6,294k at the end of FY 2021 to £2,963k a year later but this was much higher than our previous FY 2022 estimate and we have aligned with the higher YE 2022 cash position in RUA’s trading update. While the delay to the launch of RUA Vascular’s products in the US and EU to 2025 may disappoint some, the generation of data that establishes the safety and efficacy of Elast-Eon as a graft sealant has a number of competitive advantages. Our valuation has been updated for RUA’s trading statement with the only change reflecting the cash consumption. This modestly decreased our valuation to £121.0m or 545p per share from £122.9m or 554p per share.

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here
See all the research we have on this company.

The pandemic clouds disperse


RUA Life Sciences Plc (RUA:LON) | 41.0 0 0.0% | Mkt Cap: 9.10m


  • Published: 27 May 2022
  • Author: Andy Smith
  • Pages: 5
  • Equity Development


RUA Life Sciences’ trading update illustrated both a recovery from the challenges of the pandemic faced by medical device companies which translated into increased revenues at RUA Medical Devices and increased investment in its vascular and heart valve products. RUA’s cash balance has decreased from £6,294k at the end of FY 2021 to £2,963k a year later but this was much higher than our previous FY 2022 estimate and we have aligned with the higher YE 2022 cash position in RUA’s trading update. While the delay to the launch of RUA Vascular’s products in the US and EU to 2025 may disappoint some, the generation of data that establishes the safety and efficacy of Elast-Eon as a graft sealant has a number of competitive advantages. Our valuation has been updated for RUA’s trading statement with the only change reflecting the cash consumption. This modestly decreased our valuation to £121.0m or 545p per share from £122.9m or 554p per share.

More Content

More Content

Cenkos: RUA Life Sciences Plc -- Vascular graft distribution agreement

Companies: RUA Life Sciences Plc

Cenkos Securities

RUA Life Sciences Investor Presentation July 22

Companies: RUA Life Sciences Plc

Equity Development

Commercialisation partnership signed

Companies: RUA Life Sciences Plc

Equity Development

RUA LIfe Sciences' Chairman Trading Update Interview

Companies: RUA Life Sciences Plc

Equity Development

This Week's AIM Highlights 16th December 2022

Companies: RUA ORR INL TWD KIBO

Kemeny Capital

Useful Links

  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub

Account

  • Login
  • Free Trial - Join Now
  • Contact
Follow us on Linkedin Follow us on Twitter

Share:

Copyright © 2023 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Blogs
    • Academy
    • Insights
    • News
    • Research Tree
    • The Naked Fund Manager
  • Ideas & Picks
    • Ideas Hub
    • Stock Pick League
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Utilities
    • AIC Sectors
      • Asia Pacific
      • Asia Pacific Equity Income
      • Asia Pacific Smaller Companies
      • Biotechnology & Healthcare
      • China / Greater China
      • Commodities & Natural Resources
      • Country Specialist
      • Debt - Direct Lending
      • Debt - Loans & Bonds
      • Debt - Structured Finance
      • Environmental
      • Europe
      • European Smaller Companies
      • Farmland & Forestry
      • Financials
      • Flexible Investment
      • Global
      • Global Emerging Markets
      • Global Equity Income
      • Global Smaller Companies
      • Growth Capital
      • Hedge Funds
      • India
      • Infrastructure
      • Infrastructure Securities
      • Insurance & Reinsurance Strategies
      • Japan
      • Japanese Smaller Companies
      • Latin America
      • Leasing
      • Liquidity Funds
      • North America
      • North American Smaller Companies
      • Private Equity
      • Property - Debt
      • Property - Europe
      • Property - Rest of World
      • Property - UK Commercial
      • Property - UK Logistics
      • Property - UK Residential
      • Property Securities
      • Renewable Energy Infrastructure
      • Technology & Media
      • UK All Companies
      • UK Equity & Bond Income
      • UK Equity Income
      • UK Smaller Companies
      • VCT AIM Quoted
      • VCT Generalist
      • VCT Generalist Pre Qualifying
      • VCT Specialist: Environmental
      • VCT Specialist: Environmental Pre Qualifying
      • VCT Specialist: Healthcare & Biotechnology
    • Trust Managers
      • 3i Group
      • 3i Investments
      • Aberforth Partners
      • abrdn
      • AEW UK Investment Management
      • Albion Capital
      • Allianz Global Investors
      • Alpha Real Capital
      • Amati Global Investors
      • Amedeo Air Four Plus
      • Apax Guernsey Managers
      • Aquila Capital Investment
      • Artemis Investment Management
      • Asset Value Investors
      • Athelney Trust
      • Atrato Partners Limited
      • Augmentum Capital
      • Axiom Alternative Investments
      • Baillie Gifford
      • Baker Steel Capital
      • Beringea
      • BlackRock Investment Management (UK)
      • Boussard & Gavaudan Asset Management
      • Brevan Howard Capital Management
      • Chelverton Asset Management
      • Columbia Threadneedle
      • CVC Credit Partners
      • Doric Partners
      • Ecofin
      • Fidelity
      • Foresight Group
      • Frostrow Capital
      • Fundsmith
      • Gravis Capital Management
      • Greencoat Capital
      • Gresham House
      • Hansa Capital Partners
      • Harwood Capital
      • ICM
      • InfraRed Capital Partners
      • Invesco Asset Management
      • J.P. Morgan Asset Management
      • Janus Henderson Investors
      • Jupiter Unit Trust Managers
      • KKV Investment Management
      • Liontrust Asset Management
      • Markel CATCo Investment Management
      • Maven Capital Partners
      • MD Barnard and Co
      • Mercia Asset Management
      • Montanaro Investment Managers
      • Neuberger Berman Europe
      • New City Investment Managers
      • Octopus Investments
      • Pantheon Ventures
      • Phoenix Asset Management
      • Polar Capital Holdings
      • Premier Miton
      • Puma Investments
      • Quaero Capital
      • Rampart Capital
      • Ravenscroft
      • Riverstone International
      • Schroder Investment Management
      • Schroder Real Estate Management
      • Seneca Investment Managers
      • Triple Point Investment Management
      • Tritax Management
      • Troy Asset Management
      • TwentyFour Asset Management
      • White Oak Capital Partners
      • Willis Towers Watson
      • YFM Private Equity
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • ACF Equity Research
      • Align Research
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • Equity Development
      • eResearch
      • Fidante Partners
      • Five Minute Pitch TV
      • goetzpartners securities Limited
      • Hardman & Co
      • Inbound Capital
      • Independent Investment Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Magnitogorsk Iron and steel works
      • Mello Events
      • Mining Network
      • piworld.co.uk
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • RaaS - Research as a Service
      • Radnor Capital Partners
      • Research Tree
      • SEAL Advisors Ltd
      • ShareSoc
      • The AIC
      • Trinity Delta
      • UK Investor Group
      • Vox Markets
      • Yellowstone Advisory
    • High Net Worth Offering
      • Fox-Davies Capital
      • ACF Equity Research
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cenkos Securities
      • Couloir Capital
      • Dowgate Capital
      • finnCap
      • First Berlin
      • First Sentinel
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Liberum
      • Longspur Research
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • The Life Sciences Division
      • VSA Capital
      • WHIreland
      • Whitman Howard
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ACF Equity Research
      • Align Research
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Atrium Research
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane
      • BNP Paribas Exane - Sponsored Research
      • BRR Media
      • Bryan, Garnier & Co
      • Calderwood Capital
      • Calvine Partners
      • Canaccord Genuity
      • Capital Access Group
      • Cenkos Securities
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Degroof Petercam
      • Doceo
      • Dowgate Capital
      • Edison
      • Equity Development
      • eResearch
      • Fidante Partners
      • finnCap
      • First Berlin
      • First Sentinel
      • Five Minute Pitch TV
      • goetzpartners securities Limited
      • Hannam & Partners
      • Hardman & Co
      • Hybridan
      • Hypothesis Research
      • Inbound Capital
      • Independent Investment Research
      • InterAxS Global
      • Kemeny Capital
      • Kepler | Absolute Hedge
      • Kepler | Trust Intelligence
      • Liberum
      • London Stock Exchange
      • Longspur Research
      • Magnitogorsk Iron and steel works
      • Mello Events
      • Mining Network
      • Northland Capital Partners
      • Numis
      • Panmure Gordon
      • Peel Hunt
      • piworld.co.uk
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • RaaS - Research as a Service
      • Radnor Capital Partners
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • SI Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • Stifel FirstEnergy
      • StockBox Media
      • Stockdale Securities
      • Tamesis Partners
      • The AIC
      • The Life Sciences Division
      • Trinity Delta
      • UK Investor Group
      • Velocity Trade
      • Vox Markets
      • VSA Capital
      • WHIreland
      • Whitman Howard
      • Winterflood Securities
      • Yellowstone Advisory
      • Zeus Capital
    • Video/Audio Interviews
      • BRR Media
      • Capital Access Group
      • Couloir Capital
      • Doceo
      • Edison
      • Equity Development
      • Five Minute Pitch TV
      • Mining Network
      • piworld.co.uk
      • Proactive
      • QuotedData
      • RaaS - Research as a Service
      • Research Tree
      • UK Investor Group
      • Vox Markets
      • Yellowstone Advisory
    • Event Providers
      • Capital Access Group
      • Cenkos Securities
      • Couloir Capital
      • Edison
      • Equity Development
      • Five Minute Pitch TV
      • Hardman & Co
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Mello Events
      • piworld.co.uk
      • Proactive
      • QuotedData
      • Research Tree
      • ShareSoc
      • StockBox Media
      • The AIC
      • UK Investor Group
      • VSA Capital
      • Yellowstone Advisory
  • Contact
  • Sign Up
  • Sign In